Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Neose Technologies initiates phase II trials with antiulcer drug

May 8, 1997

Preliminary clinical results for Lexirin

May 8, 1997

Maxim starts clinical trial of Maxamine in hepatitis C

May 8, 1997

Kaneka discloses anti-H. pylori rifamycins

May 6, 1997

Prokinetic agents from Kyorin

May 6, 1997

Positive results from preclinical studies with darifenacin

May 5, 1997

Positive preclinical results for T-330 in animal models of gastric ulcers

April 30, 1997

BMS-200475: profile of a novel anti-hepatitis B compound

April 30, 1997

Compounds combining PAF antagonist and 5-ASA claimed by Uriach for IBD

April 29, 1997

Novopharm and Glaxo Wellcome reach agreement for ranitidine

April 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...